This cluster groups 2 independently calculated changes: Cash & equivalents decreased 6.5%; Operating cash flow decreased 17.1%.
2 evidence-backed components· Pharmaceutical Preparations
RESEARCH SNAPSHOTAnixa Biosciences Inc's latest supported as-filed period reports revenue of $210,000. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents decreased 6.5%; Operating cash flow decreased 17.1%.
2 evidence-backed componentsShares outstanding changed +5.6% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ANIX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-042302SEC ↗10-QSep 9, 2026Period Jul 31, 20260001493152-26-041963SEC ↗4Aug 3, 2026Period Jul 31, 20260001493152-26-035751SEC ↗4Jul 29, 2026Period Jul 27, 20260001493152-26-035122SEC ↗4Jul 28, 2026Period Jul 27, 20260001493152-26-034952SEC ↗4Jul 27, 2026Period Jul 27, 20260001493152-26-034772SEC ↗4Jul 27, 2026Period Jul 24, 20260001493152-26-034723SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating cash flow changed -17.1% from the comparable as-filed period.
Research & development changed +25.7% from the comparable as-filed period.
Operating income changed -12.4% from the comparable as-filed period.
Stock-based compensation changed -23.2% from the comparable as-filed period.
Net income changed -15.4% from the comparable as-filed period.
Current liabilities changed -15.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-07-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-034027